Relation - About the company
Relation is a seed company based in London (United Kingdom), founded in 2019 by Charles Roberts and Benjamin Swerner. It operates as an AI-based drug development tools for researchers. Relation has raised $116M in funding from DCVC and Magnetic Ventures. The company has 162 active competitors, including 67 funded and 9 that have exited. Its top competitors include companies like Evotec, DNAnexus and Insitro.
Company Details
AI-based drug development tools for researchers. The company has developed software for target and drug discovery. The platform leverages human genetics, single-cell omics, and perturbational data for genetic disease management.
- Website
- www.relationrx.com/
- Social
- Email ID
- *****@relationrx.com
Key Metrics
Founded Year
2019
Location
London, United Kingdom
Stage
Seed
Total Funding
$116M in 5 rounds
Latest Funding Round
Ranked
9th among 162 active competitors
Employee Count
130 as on May 31, 2026
Similar Companies
Legal entities associated with Relation
Relation is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Relation Therapeutics Ltd CIN: 12305953 , United Kingdom, Active | Nov 07, 2019 | - | 6 (As on Nov 30, 2020) | |
RELATION THERAPEUTICS LIMITED CIN: 12305953 , United Kingdom, Active | Nov 07, 2019 | - | - |
Sign up to download Relation's company profile
Relation's funding and investors
Relation has raised a total funding of $116M over 5 rounds. Its first funding round was on Aug 10, 2021. Its latest funding round was a Seed round on Nov 21, 2025 for $*****. 3 investors participated in its latest round. Relation has 10 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Relation:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 21, 2025 | 6810958 | Seed | 2899032 | 6204817 | 3202065 | 3784622 |
Nov 22, 2024 | 6436473 | Seed | 5777374 | 8689928 | 4533702 | |
Jan 09, 2024 | 1455194 | Seed | 6227801 | 4334343 |
Access funding benchmarks and valuations. Sign up today!View details of Relation's funding rounds and investors
Relation's founders and board of directors
Founder? Claim ProfileThe founders of Relation are Charles Roberts and Benjamin Swerner. David Roblin is the CEO of Relation.
Here are the details of Relation's key team members:
- Charles Roberts: Co-Founder of Relation and founder of 1 other company. They are also an angel investor in 1 startup.
- Benjamin Swerner: Co-Founder & COO of Relation.
- David Roblin: CEO of Relation. Contact Info: 1 email address
View details of Relation's Founder profiles and Board Members
Relation's employee count trend
Relation has 130 employees as of May 26. Here is Relation's employee count trend over the years:
Uncover Relation's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Relation's Competitors and alternates
Top competitors of Relation include Evotec, DNAnexus and Insitro. Here is the list of Top 10 competitors of Relation, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AI-driven life science company accelerating drug discovery and development | $25.1M | 76/100 | ||
2nd |  DNAnexus 2009, Mountain View (United States), Series H | Provider of cloud-based genome informatics & data management platform | $473M | 71/100 | |
3rd |  Insitro 2018, San Francisco (United States), Series C | Developer of machine learning platform for drug discovery and development | $643M | 70/100 | |
4th | Immunai Technologies 2018, United States, Series B | Developer of next-generation of immunomodulatory therapeutics | $295M | 66/100 | |
5th |  NewLimit 2022, San Francisco (United States), Series C | Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension | $682M | 65/100 | |
6th |  Asimov 2017, Boston (United States), Series B | Provider of integrated suite for advanced genetic design and manufacturing | $234M | 65/100 | |
7th | Metagenomi 2016, Berkeley (United States), Public | Digital gene editing technologies for drug development | $376M | 64/100 | |
8th | _1569310612679.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kinomica 2017, Macclesfield (United Kingdom), Series A | Provider of a bioinformatics platform for the development of precision medicine | $5.16M | 64/100 | |
9th | Relation 2019, London (United Kingdom), Seed | AI-based drug development tools for researchers | $116M | 64/100 | |
10th |  Somite 2023, Boston (United States), Series A | AI-driven platform to produce human tissue for cell-based therapies | $60M | 63/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Relation's competitors? Click here to see the top ones
Relation's Investments and acquisitions
Relation has made no investments or acquisitions yet.
Reports related to Relation
Here is the latest report on Relation's geography:
News related to Relation
Media has covered Relation for a total of 4 events in the last 1 year, 2 of them have been about partnerships and 1 about company updates.
•
•
Relation Raises Additional $26M InvestmentFinSMEs•Dec 11, 2025•DCVC, Magnetic Ventures, Relation, NVentures
•
Novartis partners with AI-focused Relation on atopic diseasesEndpoints•Dec 09, 2025•Novartis, Relation
•
•
•
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture armAsiaone•Mar 14, 2024•Relation, NVentures, Nvidia, Khosla Ventures and 4 others
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Relation
Explore our recently published companies
- Boltzbit - London based, 2020 founded, Seed company
- Circlegas - United Kingdom based, Unfunded company
- Optispan life - Unfunded company
- Clinical Education Alliance - Reston based, 2020 founded, Funding Raised company
- Pritam Jeweller - 2018 founded, Unfunded company
- Spring - New Haven based, 2016 founded, Early Stage company
